HCPCS Level II

J0179

Injection, brolucizumab-dbll, 1 mg

Ask Rivvi

00078-0827-60 Beovu, Novartis Pharmaceuticals Corporation. Billable units per 11-digit NDC: 6.

Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.

Free to start. Most teams are using it the same day.